Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

DuPont Displays Essential Pharmaceutical Portfolio, Vital Expertise at CPhI Worldwide
  • USA - English


News provided by

DuPont (Pharma Applications)

Nov 04, 2019, 07:55 ET

Share this article

Share toX

Share this article

Share toX


WILMINGTON, Del. (PRWEB) November 04, 2019 -- DuPont draws on a rich 120-year history of pharmaceutical industry and technical knowledge, a broad portfolio, and regulatory and quality expertise to consistently help advance its customers forward. Global experts bring this spirit to CPhI Worldwide, Nov. 5-7, where they will collaborate with customers to optimize offerings that help manage everyday and future challenges. During the three-day conference, experts will be on-site at stand 102A30 to discuss DuPont’s:

Our wide network across the company also ensures connected solutions, embedded with QbD expertise and a passion for innovation to help our customers deliver on the promise of a healthier life.

Post this
  • Broad, reliable product portfolio that addresses a wide range of challenges, allowing customers to increase efficiency of formulation development and performance, while reducing difficulty and cost.

● DuPont’s excipient portfolio is one of the most robust for oral solid dosage formulations including tablets, capsules, solutions and suspension, including Immediate and Controlled Release, taste-masking, solubility and vegetarian capsules.
● DuPont’s experience in developing and commercializing silicone materials for healthcare applications is extensive. The portfolio includes fluids, blends, resins, waxes and emulsifiers that deliver the performance consumers expect and regulatory compliance formulators need. Products are designed to increase spreading, enhance sensory aesthetics and improve efficacy of APIs. With these attributes, DuPont silicones enable acne medications and are first-line therapy for scar and stretch mark management.
○ DuPont’s silicone adhesives are used in a wide range of pharmaceutical applications, including line pressure sensitive adhesives specifically for the preparation of transdermal and topical drug delivery systems.
○ DOW CORNING™ brand pharma single-use tubing and overmolded assemblies are part of the DuPont portfolio. These silicone elastomer solutions are designed to advance purity, reliability and security in biopharmaceutical processing.
● DuPont™ HOWARU® line features a broad portfolio of clinically mastered probiotic solutions that are offered as single strains or pre-formulated blends, all validated by gold-standard clinical trials. Each robust strain or strain-combination provides an array of benefits sure to meet the manufacturing needs of unique customers.
● As one of the largest manufacturers of ion exchange resins and polymeric adsorbents worldwide, DuPont offers a broad range of separation and purification products specifically designed to be used in bioprocessing.

  • Advances in capacity and manufacturing excellence, creating shorter lead times and greater flexibility and reliability for customers in Europe and India.

● DuPont was awarded EXCiPACT Good Manufacturing Practice (GMP) Certification Standards at its METHOCEL™ and ETHOCEL™ excipient facilities in Midland, MI; Plaquemine, LA; Bomlitz, Germany; and POLYOX™ plant in Institute, WV.
● The company has increased capacity for its METHOCEL™ K100M Premium HPMC product, which is now produced at both the Midland and Stade, Germany, facilities. Production expansion is in response to strong market demand and the desire to improve reliability and ensure business continuity plans.
● DuPont also will present at the CPhI Theatre on Continuous Manufacturing: Current and Future Role of Excipient Suppliers Nov. 5, 12:30-1 p.m. CEST. Meinolf Brackhagen, Ph.D., Principal Scientist, will share insights on using continuous manufacturing to overcome oral solid drug production challenges to improve quality and productivity.

  • DuPont provides polymer expertise in optimizing critical material attributes and facilitating robust formulation and process early in the product development.
  • This offering of Quality by Design components, such as historical manufacturing data and variability analysis (Multivariate Analysis) to improve scale up, robust manufacturing process, and lower manufacturing costs.
  • DuPont offers global regulatory proficiency with strong collaboration with the International Pharmaceutical Excipients Council to help customers navigate regulation differences across borders.

“We are with our customers at every step of the process to overcome challenges and help them develop high-quality offerings that meet regulatory standards around the world,” said Angela Strzelecki, Global Business Director, Pharma Solutions at DuPont Nutrition & Biosciences. “Our wide network across the company also ensures connected solutions, embedded with QbD expertise and a passion for innovation to help our customers deliver on the promise of a healthier life.”

In addition to its stand presence, DuPont will again sponsor the Sixth Annual Women in Leadership Forum on Nov. 6, 3:30-6:30 p.m. CEST at Frankfurt Marriot Hotel, across from the CPhI event location. DuPont extends its commitment to propelling diversity and inclusive initiatives forward at the event, which Strzelecki and other DuPont leaders will keynote and facilitate. The forum will cover how organizations can create a ‘future-fit’ environment to champion women to bring their full selves to work.

To learn more about DuPont’s portfolio of high-quality pharmaceuticals, technologies and proven expertise, visit CPhI Worldwide stand 102A30 or pharma.dupont.com.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food and worker safety. More information can be found at http://www.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. Dow Corning is a trademark of the Dow Chemical Company or its affiliates.

Lindsay Torriero, DuPont (Pharma Applications), https://www.pharma.dupont.com/, +1-407-701-2133, [email protected]

Modal title

Solution Experts from DuPont to Attend CPhI Worldwide
Solution Experts from DuPont to Attend CPhI Worldwide
Solution Experts from DuPont to Attend CPhI Worldwide

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.